U.S. FDA panel votes against approval of Nektar's opioid painkiller
Independent advisers to the U.S. Food and Drug Administration on Tuesday unanimously voted against Nektar Therapeutics' opioid painkiller for adults with chronic low back pain, sending the drug developer's shares down 12% in extended trading.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Back Pain | Chronic Pain | Food and Drug Administration (FDA) | Health | Low Back Pain | Pain